Today’s guest is Jane Chen, Director of Commercial Analytics for Women’s Cancer at Novartis. Jane joins us on the program today to highlight challenges in identifying and segmenting specific patient groups, particularly those with rare or niched diseases. Throughout the episode, she sheds a spotlight on privacy concerns in healthcare data, including blind spots due to HIPAA regulations. Later, she explains the ways healthcare leaders are testing the waters for generative AI applications in healthcare. If you’ve enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!